Thiotepa Injection, Powder, For Solution
Product Images NDC 71288-157

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 71288-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Thiotepa For Injection, Usp 100 mg Carton (Thiotepa Carton 100mg)

Packaging label for Thiotepa injection, USP 100 mg per vial by Meitheal Pharmaceuticals Inc. The label indicates the product is a sterile, single-dose vial for intravenous, intracavitary, or intravesical use. It includes storage instructions to refrigerate between 2° to 8°C, cautions that it is a cytotoxic agent, and notes that the container is preservative-free and latex-free. The label also displays NDC 71288-157-10 and includes a barcode.*

FDA Label Image

Principal Display Panel – Thiotepa For Injection, Usp 15 mg Carton (Thiotepa Carton 15mg)

Label for Thiotepa Injection, USP 15 mg per vial by Meitheal Pharmaceuticals Inc. The label states it is for intravenous, intracavitary, or intravesical use. It is a single-dose sterile vial labeled as a cytotoxic agent. Storage instructions and reconstitution details are provided on the side panel, including refrigeration requirements and preservative-free status.*

FDA Label Image

Structural Formula (Thiotepa Structure)

Chemical structure diagram of Thiotepa showing the phosphorus atom bonded to three nitrogen-containing aziridine rings and one sulfur atom, representing the active ingredient Thiotepa.*

FDA Label Image

Principal Display Panel – Thiotepa For Injection, Usp 100 mg Vial Label (Thiotepa Vial 100mg)

Label for Thiotepa 100 mg per vial injection powder for solution by Meitheal Pharmaceuticals Inc. It is indicated for intravenous, intracavitary, or intravesical use as a single-dose vial. The label includes storage instructions and cautions, a barcode, and manufacturer details.*

FDA Label Image

Principal Display Panel – Thiotepa For Injection, Usp 15 mg Vial Label (Thiotepa Vial 15mg)

Label for Thiotepa for Injection, USP 15 mg per vial, a powder for solution intended for intravenous, intracavitary, or intravesical use. This single-dose vial label includes storage instructions, cautions about the product being a cytotoxic agent, and manufacturing information by Meitheal Pharmaceuticals Inc, with NDC 71288-156-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.